Research programme: anticancer proteins - Maxygen
Alternative Names: Maxy 14; Maxy 912; Maxy 914Latest Information Update: 07 Jun 2013
At a glance
- Originator Maxygen
- Class Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 07 Jun 2013 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 06 Jun 2006 No development reported - Preclinical for Cancer in USA (unspecified route)
- 01 Jun 2005 Preclinical trials in Cancer in USA (unspecified route)